Page last updated: 2024-08-21

tetramethylpyrazine and Muscular Diseases

tetramethylpyrazine has been researched along with Muscular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ge, Q; Jiang, S; Li, X; Liu, Y	1

Other Studies

1 other study(ies) available for tetramethylpyrazine and Muscular Diseases

Article	Year
Tetramethylpyrazine protects against high glucose-induced vascular smooth muscle cell injury through inhibiting the phosphorylation of JNK, p38MAPK, and ERK. The Journal of international medical research, 2018, Volume: 46, Issue:8 Topics: Animals; Aorta, Thoracic; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Glucose; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Muscular Diseases; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrazines; Rats; Signal Transduction; Vascular Diseases; Vasodilator Agents	2018

Article

Year

Tetramethylpyrazine protects against high glucose-induced vascular smooth muscle cell injury through inhibiting the phosphorylation of JNK, p38MAPK, and ERK.

The Journal of international medical research, 2018, Volume: 46, Issue:8

Topics: Animals; Aorta, Thoracic; Cells, Cultured; Extracellular Signal-Regulated MAP Kinases; Glucose; Hyperglycemia; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Muscular Diseases; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyrazines; Rats; Signal Transduction; Vascular Diseases; Vasodilator Agents

2018